The Europe home care market size was valued at USD 123.4 billion in 2024 and is projected to grow at a CAGR of 7.7% from 2025 to 2030. Market growth in the region is driven by the growing geriatric population in the region and the rising incidence of chronic diseases. According to the EC Ageing Report from 2024, public spending (on healthcare, long-term care, pension, etc.) is expected to increase to 25.6% of the total GDP of the European Union by 2070. In addition, technological advancements in medical devices, rising prevalence of chronic diseases, and cost-effectiveness of home care have led to significant growth in home care devices and services in the European market.
A primary driver is the increasing awareness and acceptance of home care services as a viable and often preferable alternative to traditional institutional care settings. This shift is further amplified by the introduction of innovative medical devices designed for in-home use, enabling the effective management of various health conditions within a patient’s residence. The availability of portable and user-friendly devices, such as heart rate monitors, intravenous pumps, and blood glucose monitors, has notably enhanced the efficiency and overall effectiveness of home care, particularly for individuals managing chronic lifestyle diseases.
The escalating prevalence of respiratory illnesses across Europe, including conditions such as asthma, chronic obstructive pulmonary disease (COPD), and sleep apnea, is also a substantial catalyst for the expansion of the respiratory care devices segment within the home care market. This rise in respiratory ailments can be attributed to factors such as increasing levels of air pollution, the prevalence of smoking, and the adoption of less healthy lifestyle choices by a segment of the population. Consequently, the demand for home-based respiratory support and monitoring devices is on an upward trend.
The European regulatory landscape plays a vital role in ensuring the safety and efficacy of medical devices utilized in home care. Strict legal frameworks oversee medical devices throughout their entire lifecycle, from initial design and manufacturing to application and maintenance. These regulations assure both healthcare providers and patients regarding the reliability and performance of home-based medical technologies.
In the UK, the Health and Social Care Secretary has introduced a new qualification designed to modernize social care practices and reduce hospital admissions. This initiative focuses on empowering care leaders with the skills necessary to effectively integrate and utilize technology within care environments, aligning with the government’s broader long-term health plan. The training program specifically emphasizes the adoption of proven technologies, such as motion sensor systems that can alert caregivers to patient falls, with the dual goals of enhancing the quality of care provided and alleviating the workload on healthcare staff. This proactive approach to technological integration underscores the growing recognition of home care’s importance within the broader European healthcare ecosystem.
The EU4Health Programme represents a significant strategic initiative bolstering health systems throughout Europe, with home care being a key area of focus. This program actively promotes the digital transformation of healthcare services, which is considered crucial for the advancement and widespread adoption of remote home care solutions. The emphasis on digital integration aims to improve accessibility, efficiency, and the quality of care delivered in domestic settings.
The market growth stage is high, and the pace of the market growth is accelerating. The home care sector in Europe is currently in a growth and adoption stage of innovation, driven by an aging population and increased demand for personalized, in-home services. Several countries are integrating digital health technologies, such as remote monitoring and telehealth, to enhance efficiency and quality of care. Government support, along with public and private investments, has accelerated the development of smart care solutions.
Mergers and acquisitions in the home care sector across Europe are on the rise, driven by the need to scale operations and improve service efficiency. As demand for home care services increases, companies are consolidating to expand their geographic reach and strengthen their workforce. Investors are also attracted to the sector’s long-term growth potential, especially with aging populations across the continent. Moreover, M&A activity helps providers adopt new technologies and streamline administrative functions, enhancing overall care delivery.
Regulatory scrutiny of the home care market in Europe has been intensifying, driven by the growing demand for high-quality, safe, and effective in-home care services. As more people seek home care options due to an aging population and increasing health awareness, governments are implementing stricter regulations to ensure the quality, safety, and reliability of these services. In the European Union, the European Commission plays a pivotal role in shaping the regulatory framework through its European Care Strategy, which focuses on improving long-term care services across member states. Furthermore, individual countries such as Germany and France have their own regulatory bodies, such as the Federal Ministry of Health and the Ministry of Social Affairs and Health, which oversee home care standards and ensure compliance with the EU directives. These regulations significantly influence the structure and delivery of home care services, aiming to improve patient outcomes and maintain service consistency across the region.
In the European home care market, substitutes such as nursing homes offer intensive, round-the-clock care. Telemedicine and remote monitoring allow remote consultations and vital sign tracking. Assistive technologies such as smart home devices and AI tools help with daily tasks and medication management, reducing reliance on human caregivers. These alternatives provide flexible options based on care needs and personal preferences.
The services segment dominated the market with a revenue share of 83.9% in 2024. Many elderly and chronically ill individuals increasingly prefer receiving care within their familiar home environment, valuing independence and personalized attention. Concurrently, diminished informal care capacity due to smaller families and increased workforce participation necessitates formal services. The rising burden of chronic diseases further drives the need for sustained in-home management. Moreover, home care’s cost-effectiveness compared to institutional stays and technological advancements in remote care delivery contribute significantly to this growing preference, supported by favorable government policies and reimbursement frameworks across the continent.
Home care equipment is expected to grow at the fastest rate of 8.3% over the forecast period, driven by a growing elderly population needing support for independent living. The rising prevalence of chronic diseases necessitates devices for effective at-home management. A broader shift towards home-based care requires more diagnostic and therapeutic equipment in domestic settings. Technological progress in user-friendly devices and remote monitoring makes home care feasible, offering cost savings incentivized by governments and insurers.
Cancer care dominated the segment with a revenue share of 26.0% in 2024. The increasing demand for home care for cancer in Europe is driven by its rapidly aging population and the associated rise in cancer incidence, necessitating long-term support at home. According to the European Commission, European Cancer Information System estimates indicate that by 2025, new cancer cases and cancer-related deaths in the older population are projected to increase by roughly 31% and 35%, respectively, solely due to population aging. Projected healthcare workforce shortages by 2030 further necessitate home-based solutions. Many patients prefer the comfort of their homes, improving their quality of life. Home care also offers cost efficiencies and is facilitated by technological advancements such as remote monitoring and AI diagnostics. European governments are increasingly integrating home healthcare into their public health systems. In April 2024, the European Health and Digital Executive Agency (Europe) launched a call for proposals to develop a pilot information portal for the European Cancer Patient Digital Centre. This portal aimed to support the information needs of cancer patients, survivors, and caregivers, covering the entire cancer patient journey.
The diabetes and kidney disorder segments are expected to grow at the fastest rate of 14.2% over the forecast period. According to a 2024 article by Politico, CKD affects 1 in 10 adults in the region. Moreover, in 2024, the International Diabetes Federation reported that Europe had the highest global prevalence of type 1 diabetes, affecting 2.7 million individuals. Patients increasingly prefer home care for independence, despite low home dialysis adoption. Home care is cost-effective, potentially reducing hospitalization risks, which are higher for diabetic home care recipients without adequate support. Technological integration, including glucose monitors and telehealth, aids remote management. Policy shifts aim to reduce hospital strain and support aging populations. However, workforce shortages and fragmented reimbursement remain key challenges in meeting the rising demand for home-centric care.
Germany home care market dominated the Europe market with a revenue share of 24.5% in 2024, fueled by the aging population and favorable universal healthcare coverage system. The national Long-Term Care Insurance (LTCI) system, established in 1995, ensures broad access to home care services. Germany’s advanced healthcare infrastructure and government support, including insurance subsidies, facilitate the rapid adoption of innovative home care technologies. Growing patient preference for at-home care, a focus on personalized prevention, and the quality of German medical technology further contribute to this market leadership.
The home care market in UK is expected to grow lucratively from 2025 to 2030. In the UK, the increasing demand for home care is driven by government “Hospital-at-Home” initiatives and advanced telecare adoption for remote monitoring. According to a 2024 NCHA report, 75,000 patients in the UK avoided hospital visits, demonstrating the potential of home care to overcome geographical limitations. Strong public-private partnerships accelerate innovation. A growing geriatric population with rising chronic disease rates increases the need for home-based medical devices. Post-Brexit regulatory agility allows quicker device approvals. The NHS prioritizes cost-effective home care models and leads in palliative and post-surgical at-home care. Consumer preference for independence and self-management tools further fuels this demand.
The Portugal home care market is expected to grow at the fastest CAGR of 9.9% over the forecast period. Portugal’s home care market is expanding due to its rapidly aging population and the increasing prevalence of chronic diseases, driving demand for in-home care and monitoring devices. A fragmented public health infrastructure pushes families towards private and non-profit providers (IPSS), which are key in delivering affordable services despite coordination challenges. According to Freopp, Portugal’s healthcare system demonstrates high quality, ranking 11th globally, with exceptional patient-centered care. Its medical infrastructure is particularly strong, achieving 3rd place, supported by a high density of primary care physicians and efficient hospital utilization. Portable devices and EU-funded projects in the country are modernizing home care systems.
Some of the key companies in home care market include Siemens Healthineers AG; Medtronic; Health Care At Home Private Limited; BAYADA Home Health Care; and others. The market is witnessing increased competition and consolidation; technological advancements such as telehealth are reshaping service delivery.
Mears Group PLC, primarily UK-focused, offers housing with integrated 24/7 personalized care across 21 extra care schemes and 40 housing-with-care developments. As the UK’s largest temporary accommodation provider and manager of over 750,000 social housing units, Mears integrates housing, care, and maintenance, leveraging data for proactive solutions and emphasizing social responsibility.
Omron Healthcare is recognized for its home healthcare solutions and devices, with varied offerings such as digital blood pressure monitors, nebulizers, thermometers, and devices for pain relief management. Omron empowers patients to monitor and manage their health independently while supporting caregivers in providing more effective care.
In April 2025, DomusVi (Spain) divested its Spanish mental health division, Mentalia Salud, to Neural, a Spanish neurorehabilitation company, to focus on core elderly care services.
In February 2025, Siemens (Germany) announced the sale of approximately 2% of its stake in Siemens Healthineers AG to qualified investors via a private placement for general corporate purposes.
In December 2024, Mutares SE & Co. KGaA acquired Alcura France from Alliance Healthcare Group France. This acquisition supports Mutares’s strategy to strengthen its Goods & Services division and take advantage of the rising demand for home care services, fueled by an aging population and the growing shift towards outpatient care.
In October 2024, Unilever (Europe) announced a EUR 150 million (~USD 173 million) investment to overhaul its European homecare supply chain, aiming to improve performance and attract younger consumers.
In October 2024, Parkway Life REIT (Singapore) announced the acquisition of eleven nursing homes in France from the DomusVi Group for approximately ~USD 126-128 million.
In August 2024, Mears Group (UK) announced a new ~USD 25.4 million share buyback program, its fourth in 18 months, to return surplus capital to shareholders.
In May 2024, Future 4 Care and TNP Consultants formalized a partnership agreement. This partnership will enable TNP to work alongside its existing partners to implement cutting-edge digital healthcare solutions.
In April 2024, Air Liquide expanded its operations by acquiring homecare services in Belgium and the Netherlands. This acquisition supports Air Liquide’s broader strategy to improve patient outcomes while promoting more effective and sustainable healthcare solutions.
In April 2024, OMRON Healthcare (Japan) acquired Luscii Healthtech (Netherlands), a digital health and remote consultation platform, to advance remote patient monitoring adoption.
In January 2024, Medtronic (Europe) secured CE Mark approval for its MiniMed 780G system featuring the new, user-friendly Simplera Sync all-in-one continuous glucose monitor, facilitating its European market entry.
Report Attribute |
Details |
Revenue forecast in 2030 |
USD 192.86 billion |
Growth rate |
CAGR of 7.7% from 2025 to 2030 |
Base year for estimation |
2024 |
Historical data |
2018 - 2023 |
Forecast period |
2025 - 2030 |
Quantitative units |
Revenue in USD billion and CAGR from 2025 to 2030 |
Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
Segments covered |
Component, indication, country |
Regional scope |
Europe |
Country scope |
UK; Germany; Sweden; France; Italy; Russia; Netherlands; Spain; Portugal; Belgium |
Key companies profiled |
Siemens Healthineers AG; Medtronic; Health Care At Home Private Limited; BAYADA Home Health Care; Inizio; Accredo Health Group, Inc.; Mears Group PLC; OMRON Corporation; Johnson & Johnson Medical Limited; DomusVi Group |
Customization scope |
Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and purchase options |
Avail customized purchase options to meet your exact research needs. Explore purchase options |
This report forecasts revenue growth at regional and levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the Europe home care market report based on component, indication, and country:
Component Outlook (Revenue, USD Billion, 2018 - 2030)
Equipment
Therapeutic
Home Respiratory Equipment
Insulin Delivery Market
Home IV Pumps
Home Dialysis Equipment
Other Therapeutic Equipment
Diagnostic
Diabetic Care Unit
BP Monitors
Multi Para Diagnostic Monitors
Home Pregnancy & Fertility Kits
Apnea & Sleep Monitors
Holter Monitors
Heart Rate Meters (Include Pacemakers)
Others
Mobility Assist
Wheelchair
Home Medical Furniture
Walking Assist Devices
Services
Skilled Nursing Services
Physician Primary Care
Nursing Care
Physical/Occupational/Speech Therapy
Nutritional Support
Hospice & Palliative
Other Skilled Nursing Services
Unskilled Nursing Services
Indication Outlook (Revenue, USD Billion, 2018 - 2030)
Cardiovascular Disorder & Hypertension
Diabetes & Kidney Disorders
Neurological & Mental Disorders
Respiratory Disease & COPD
Maternal Disorders
Mobility Disorders
Cancer
Wound Care
Others
Country Outlook (Revenue, USD Billion, 2018 - 2030)
UK
Germany
Sweden
France
Italy
Russia
Netherlands
Spain
Portugal
Belgium
b. The Europe home care market size was estimated at USD 84.2 billion in 2019 and is expected to reach USD 82.3 billion in 2020.
b. The Europe home care market is expected to grow at a compound annual growth rate of 7.61% from 2020 to 2027 to reach USD 137.5 billion by 2027.
b. The services segment dominated the Europe home care market with a share of 84.3% in 2019. This is attributable to growing awareness and increasing demand for home-based care.
b. The key service providers in Europe home care market are Healthcare at Home, Bayada Home Health Care, Ashfield Healthcare, Accredo Health Group, Inc., Heritage Independent Living Ltd, Mears Group PLC.
b. Growing healthcare expenditure, availability of cost-effective alternatives enabled with technological advancements, rising geriatric population, and shifting trend from communicable to lifestyle diseases are the factors driving the Europe home care market growth.
NEED A CUSTOM REPORT?
We offer custom report options, including stand-alone sections and country-level data. Special pricing is available for start-ups and universities.
Request CustomizationWe are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
"The quality of research they have done for us has been excellent."